fda warning letters glp-1 september 2025 news sends letter after Chinese supplier breaks import restrictions FDA Issues Warning Letters Against

Wegovy recently also gained approval for the treatment of fatty liver disease (technically called metabolic dysfunction-associated steatohepatitis or MASH) in adults with moderate to advanced liver fibrosis

Characterizing factors associated with differences in FGF19 blood levels and synthesis in patients with primary bile acid diarrhea

& Mannucci, E

GLP-1 receptor agonists and renal outcomes in patients with diabetes mellitus type 2 and diabetic kidney disease: State of the art

Congenital hyperinsulinism is a heterogeneous condition in regards to genotype and phenotype

investigated the role of DPP-IV in the pathogenesis of colitis (Detel et al